Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: J Subst Abuse Treat. 2017 Mar 9;77:26–30. doi: 10.1016/j.jsat.2017.03.006

Table 3.

Physical health and other disease diagnosis (%)

No Pain
n= 1,889
OUD First
n= 515
Same Time
n= 789
Pain First
n=2,114
TOTAL
n= 5,307
Heart disease**, ab, ac, ad, bd, cd 26.8 59.6 57.2 72.0 52.5
Respiratory disease**, ab, ac, ad, bd, cd 23.7 58.1 48.2 68.4 48.5
Sleep disorder**, ab, ac, ad, bd, cd 6.7 21.4 15.7 41.8 23.4
Liver disease**, ab, ad, bc, cd 14.1 24.5 15.1 15.9 16.0
Cancer**, ad, bc, cd 9.0 16.9 11.3 23.4 15.9
Diabetes**, ab, ac, ad 6.6 16.1 13.1 19.3 13.5
STD 0.8 2.3 0.9 2.5 1.6
HIV 2.2 4.7 1.7 2.7 2.6
 Asymptomatic**, ab, bc, bd 0.9 4.1 0.8 1.6 1.5
 HIV active 2.1 4.3 1.7 2.6 2.4
HCV**, ab, ac, ad, bc, bd, cd 17.8 28.2 16.1 15.8 17.8

The group effect on each outcome variable was tested in the logistic model controlling for age, gender, ethnicity (white vs. non-white), and length of observation. A significant overall group effect is indicated by * for p<0.05 and ** for p<0.01. Significant linear tests (i.e., p<0.05) on equivalence of each pair of coefficients between No Pain (a), OUD first (b), OUD and Chronic Pain at the same time (c), and Pain first (d) are indicated by the respective groups in each pair.